Patellar Tendinopathy in NYC: When PRP Outperforms Cortisone for Jumper's Knee

Patellar tendinopathy — colloquially known as "jumper's knee" — is one of the most common overuse injuries among athletes who perform repetitive jumping, sprinting, and squatting movements. Basketball players, volleyball athletes, runners, and weightlifters are particularly susceptible. At Regen Health Physicians NYC, Dr. Ajit Dhaliwal routinely evaluates patellar tendinopathy as a condition where the standard of care — cortisone injection — is often counterproductive, and where PRP therapy offers a superior regenerative approach.

Understanding Patellar Tendinopathy

The patellar tendon connects the inferior pole of the patella (kneecap) to the tibial tubercle, transmitting the powerful quadriceps force to extend the knee. In patellar tendinopathy, repetitive loading causes degenerative changes within the tendon substance (tendinosis), not simply inflammation:

• Disorganized, immature collagen fibers replace normal parallel collagen architecture
• Increased ground substance and cellularity
• Neovascularization — aberrant new blood vessel ingrowth associated with pain
• Abnormal tenocyte activity — tendon cells produce degradative enzymes (MMPs) that further compromise structural integrity

This degenerative pathology — not inflammatory — is why anti-inflammatory treatments like corticosteroids are often ineffective or harmful in chronic patellar tendinopathy.

The Problem with Cortisone for Patellar Tendinopathy

Cortisone (corticosteroid) injection has been a first-line treatment for tendinopathy for decades, largely due to short-term pain relief. However, a substantial body of evidence now demonstrates that cortisone:

• Does not heal tendon degenerative changes — it masks pain without addressing tendinosis
• Causes collagen necrosis at the injection site — corticosteroids are directly cytotoxic to tenocytes
• Increases long-term rupture risk — a 2011 meta-analysis in Lancet found worse long-term outcomes with cortisone vs. placebo in common tendinopathies
• Repeatedly injected cortisone is associated with tendon rupture and peritendinous fat pad atrophy

For patellar tendinopathy specifically, a systematic review by Larsson et al. found that while cortisone provided superior short-term pain relief (weeks), PRP produced significantly superior outcomes at 12 months. The short-term relief from cortisone comes at the cost of long-term structural compromise.

Why PRP Is Better for Patellar Tendinopathy

Platelet-rich plasma therapy works directly with the biology of tendon healing rather than against it:

Growth Factor Delivery Targets Tendinosis

PRP delivers concentrated growth factors — PDGF, TGF-β1, IGF-1, and FGF — directly to the pathological tissue. These factors:

• Stimulate tenocyte proliferation and differentiation
• Promote synthesis of type I collagen — the structural collagen that restores tendon tensile strength
• Reduce MMP activity that is degrading tendon matrix
• Support vascular normalization (reducing the aberrant neovascularization associated with pain)

Addresses the Degenerative Process, Not Just Pain

Unlike cortisone, PRP doesn't simply suppress pain signaling — it initiates a biologically appropriate healing response. Serial ultrasound studies after PRP in patellar tendinopathy show structural improvement over 3–6 months: increased tendon echogenicity, reduced hypoechoic zones, and improved fiber organization.

Favorable Long-Term Evidence

A landmark 2010 study in the American Journal of Sports Medicine by Kon et al. compared PRP to cortisone in patellar tendinopathy and found:

• PRP superior to cortisone at 6 months (VISA-P score: PRP group significantly higher)
• PRP superior at 12 months with continued improvement
• Cortisone group deteriorated at 12 months despite initial benefit

Subsequent RCTs and meta-analyses have largely confirmed this pattern, establishing PRP as the preferred regenerative treatment for chronic patellar tendinopathy.

The RHPNY Approach

At RHPNY, patellar tendinopathy is evaluated and treated as follows:

Diagnostic Assessment

• Clinical examination: localized inferior pole tenderness, arc of pain, single-leg squat assessment
• Diagnostic ultrasound: characterizes tendon thickness, hypoechoic zones, neovascularity (using Doppler), and the extent of tendinosis
• VISA-P questionnaire to quantify functional impairment

Ultrasound-Guided PRP Protocol

• Leukocyte-rich PRP (LR-PRP) is preferred for patellar tendinopathy (some evidence suggests higher growth factor concentration improves tendinosis healing)
• Injection under real-time ultrasound guidance targeting the hypoechoic tendinosis zone
• 2–3 sessions spaced 4–6 weeks apart for most patients
• 48-hour activity modification post-injection, followed by progressive loading rehabilitation

Eccentric Loading Rehabilitation

PRP accelerates healing but does not replace rehabilitation. The Alfredson eccentric protocol and its modifications — heavy slow resistance (HSR) training — are the gold standard for remodeling the patellar tendon over 12 weeks. Dr. Dhaliwal coordinates with physical therapists experienced in tendinopathy rehabilitation.

Who Should Consider PRP for Patellar Tendinopathy?

Ideal candidates include:

• Athletes with chronic patellar tendinopathy (>3 months duration)
• Patients who have failed physical therapy without injection support
• Patients who received cortisone without durable benefit
• Anyone wanting to avoid the structural risks of repeated cortisone
• Athletes seeking return to high-level sport with a treatment that supports long-term tendon health

Getting Started in NYC

If you're dealing with persistent knee pain at the patellar tendon and want a regenerative solution, book a consultation at RHPNY to discuss PRP for your joint and orthopedic needs.

---

Medical Disclaimer: PRP therapy for patellar tendinopathy carries risks including post-injection soreness and rarely infection. Results vary by individual and injury severity. This article is educational only. Please consult a physician for personalized treatment.